Sun Pharma - Industry Insights, Financial Performance, and Market Positioning
Explore Sun Pharma's profile, vision, financial ratios, market share, product offerings, HR opportunities, and competitor analysis. Learn about their strengths and weaknesses in the pharmaceutical industry.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
PROFILE Parent Company Category Sector Tagline/ Slogan Sun Pharma Industries Pharmaceutical Healthcare Leadership through focused research Sun pharma fifth largest & most profitable company in India 12,000 Dilip shangvi USP Employess Ceo
Vision and Mission Vision: Inspiring Passion for Nature and Saving Wildlife for Future Generations. "A World without Poverty." Mission: strengthen market share and keeping customer focused
Finance Profitability Ratios 2012 2013 Net profit margin 44.23 42.46 Liquidity and solvency ratios Current Ratio 3.12 3.04 Debt Equity Ratio -- 0.01 Management Efficiency Ratios Inventory Turnover Ratio -- 3.62 Debtors Turnover Ratio 5.82 3.53 SHARE HOLDING promoters 63.68 Public share holdings 36.32
STP Cardiology, psychiatry, neurology, gastroenterology, dibetology SEGMENT Healthcare professionals, pharmacists Target They are international specialty Pharma company with strong presence in Indian & US generics market Positioning
Products Formulations ( neurology, cardiology, nephrology, orthopedics) API
HR Recruitment Selection Number of Positions Department Position Location Vacancy Code Training Executive Dadra 1 SP030 Process Engineering Manager/Senior Manager Panoli (Gujarat) 1 SP029 Technology Transfer Executive/Assistan t Manager Panoli (Gujarat) 2 SP028
competitors Ranbaxy Dr.reddy s laboratories Lupin pharmaceuticals Cipla
STRENGTH WEAKNESS 1. Strong growth in emerging market business 1. Stiff competition from many Indian and other global brands means limited market share growth 2. Introduction of Pantoprazole & Eloxatin in US market has very limited competition 2. Limited presence in emerging markets and European countries 3. They have strong marketing & sales force of over 12,000 employees 4. Strong brand presence in India and US markets SWOT OPPORTUNITIES THREATS 1. They can leverage their acquisitions to further increase the growth 1. There is growing competition in generics market 2. They can increase their presence in contract manufacturing 2. Stringent patent regulations 3. Increasing healthcare awareness in India 3. High price sensitivity of consumers
CSR NGO Education Environment
Recent news Cipla, Meda expand allergy drug collaboration Sun Pharma looking for buy out opportunity with standa New drug price policy: Which pharma cos will feel the heat? Company is in talks to buy swadesh drug maker- Meda
